Ethos Financial Group »

Moleculin Biotech shares owned by Ethos Financial Group

Quarter-by-quarter ownership of Moleculin Biotech (MBRX) shares owned by Ethos Financial Group from 13F filings

Historical chart of Ethos Financial Group investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by Ethos Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by Ethos Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.3k 10k 0.53

More positions owned by Ethos Financial Group

Schwab U.S. Broad Market Etf Etf (SCHB)
Vanguard S&P 500 Etf Etf (VOO)
Relative Sentiment Tactical Allocation Etf Etf (MOOD)
Abrdn Physical Gold Shares Etf Etf (SGOL)
Alpha Architect 13 Month Box Etf Etf (BOXX)
Schwab Us Large Cap Etf Etf (SCHX)
Vanguard Total World Stock Etf Etf (VT)
Schwab Us Large Cap Growth Etf Etf (SCHG)
Vaneck Morningstar Wide Moat Etf Etf (MOAT)
Spdr S&P 500 Etf Etf (SPY)
Invsc S P 500 Momentum Etf Etf (SPMO)
Schwab Us Large Cap Value Etf Etf (SCHV)
Ishares Tips Bond Etf Etf (TIP)
Ishares Russell 1000 Growth Etf Etf (IWF)
Select Sector Spdr Tr Etf (XLU)

View all positions for Ethos Financial Group

Top funds holding Moleculin Biotech

Vanguard Group
Geode Capital Management
Hrt Financial
LPL Financial
Ieq Capital
Wealth Dimensions Group
Rockefeller Capital Management
Cambridge Investment Research Advisors
Goldman Sachs Group
BlackRock
Branch Banking & Trust Company
Ethos Financial Group
Moors & Cabot
Tower Research Capital
UBS Group

View all funds holding Moleculin Biotech